{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:00:21Z","timestamp":1789722021662,"version":"4.0.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research and Development grants of GGD Amsterdam"},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Gilead Sciences","award":["21341"],"award-info":[{"award-number":["21341"]}]},{"name":"Stichting Aidsfonds \u2013 Soa Aids Nederland","award":["P-42701 and P- 54201"],"award-info":[{"award-number":["P-42701 and P- 54201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We assessed whether participants in the EZI-PrEP study, a non-inferiority trial evaluating online and six-monthly monitoring of oral HIV pre-exposure prophylaxis (PrEP), represent the broader population of PrEP users in the Netherlands.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cross-sectional study using routinely collected data from September 2021 to August 2022 at four centres for sexual health (CSHs) in the Netherlands. Socio-demographic characteristics, sexual behaviour, and prevalence of bacterial STIs were compared between EZI-PrEP participants at baseline and other PrEP users during their first PrEP monitoring visit during the same period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The analysis included 469 EZI-PrEP participants and 5161 other PrEP users, of whom 99% and 96% were men who have sex with men (MSM), respectively. EZI-PrEP participants were less often transgender or gender-divers persons (TGDP) (1% vs. 4%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), older (median age\u2009=\u200936 vs. 34 years,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004), more often born in the Netherlands (68% vs. 58%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and more often completed a university\/college degree (81% vs. 76%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01). They also reported more group sex (38% vs. 33%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.023) and condomless anal sex (95% vs. 92%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004), but less often sex work (1% vs. 6%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Prevalence of bacterial STIs were no different between groups (19% vs. 18%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.77).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The comparable STI prevalence suggests no difference in risk for HIV acquisition among EZI-PrEP participants and other PrEP users, making study outcomes applicable to a broader population of PrEP users. However, under-representation of TGDPs, sex workers, individuals not born in the Netherlands, and individuals without university or college degree may limit generalizability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12981-026-00886-1","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:47:27Z","timestamp":1776070047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Representativeness of participants in a randomized controlled trial on modalities of monitoring oral HIV pre-exposure prophylaxis use"],"prefix":"10.1186","volume":"23","author":[{"given":"Marije L.","family":"Groot Bruinderink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten F.","family":"Schim Van Der Loeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florien","family":"Dusseldorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Van Der Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Blitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Van Bokhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey","family":"Woudstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koenraad","family":"Vermey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Boers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maudy","family":"Sluimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelore M.","family":"G\u00f6tz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike L.","family":"Soors d\u2019Ancona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frenk","family":"Van Harreveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elske","family":"Hoornenborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udi","family":"Davidovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita W.","family":"Jongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"12","key":"886_CR1","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","volume":"30","author":"VA Fonner","year":"2016","unstructured":"Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O\u2019Reilly KR, Koechlin FM, Rodolph M, Hodges-Mameletzis I, Grant RM. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973\u201383.","journal-title":"AIDS"},{"issue":"23","key":"886_CR2","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","volume":"373","author":"JM Molina","year":"2015","unstructured":"Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, et al. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med. 2015;373(23):2237\u201346.","journal-title":"N Engl J Med"},{"issue":"9","key":"886_CR3","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1016\/S2352-3018(17)30089-9","volume":"4","author":"JM Molina","year":"2017","unstructured":"Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, Tremblay C, Rojas-Castro D, Cua E, Pasquet A, et al. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Lancet HIV. 2017;4(9):e402\u201310.","journal-title":"Lancet HIV"},{"issue":"27","key":"886_CR4","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapia M, Guanira-Carranza JV, Ramirez-Cardich ME, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587\u201399.","journal-title":"N Engl J Med"},{"issue":"10013","key":"886_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","volume":"387","author":"S McCormack","year":"2016","unstructured":"McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, Sullivan AK, Clarke A, Reeves I, Schembri G, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53\u201360.","journal-title":"Lancet"},{"issue":"4","key":"886_CR6","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1016\/S2352-3018(22)00030-3","volume":"9","author":"J Zhang","year":"2022","unstructured":"Zhang J, Li C, Xu J, Hu Z, Rutstein SE, Tucker JD, Ong JJ, Jiang Y, Geng W, Wright ST, et al. Discontinuation, suboptimal adherence, and reinitiation of oral HIV pre-exposure prophylaxis: a global systematic review and meta-analysis. Lancet HIV. 2022;9(4):e254\u201368.","journal-title":"Lancet HIV"},{"issue":"22","key":"886_CR7","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1001\/jama.2019.2591","volume":"321","author":"R Chou","year":"2019","unstructured":"Chou R, Evans C, Hoverman A, Sun C, Dana T, Bougatsos C, Grusing S, Korthuis PT. Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2019;321(22):2214\u201330.","journal-title":"JAMA"},{"issue":"2","key":"886_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10461-023-04232-8","volume":"28","author":"A van der Rotsaert","year":"2023","unstructured":"Rotsaert A, Vanhamel J, Vanbaelen T, Vuylsteke B, van der Loeff MS, Hensen B, Kielmann K, Callens S, Reyniers T. HIV pre-exposure prophylaxis (PrEP) care in Belgium: a mixed-methods study on PrEP users\u2019 experiences and service delivery preferences. AIDS Behav. 2023;28(2):393\u2013407.","journal-title":"AIDS Behav"},{"issue":"7","key":"886_CR9","doi-asserted-by":"publisher","first-page":"e528","DOI":"10.1016\/S2468-2667(21)00112-2","volume":"6","author":"BR Bavinton","year":"2021","unstructured":"Bavinton BR, Grulich AE. HIV pre-exposure prophylaxis: scaling up for impact now and in the future. Lancet Public Health. 2021;6(7):e528\u201333.","journal-title":"Lancet Public Health"},{"issue":"6","key":"886_CR10","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/eurpub\/ckab177","volume":"31","author":"DE Twisk","year":"2021","unstructured":"Twisk DE, Meima B, Nieboer D, Richardus JH, Gotz HM. Distance as explanatory factor for sexual health centre utilization: an urban population-based study in the Netherlands. Eur J Public Health. 2021;31(6):1241\u20138.","journal-title":"Eur J Public Health"},{"issue":"1","key":"886_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10461-021-03313-w","volume":"26","author":"C Owens","year":"2022","unstructured":"Owens C, Moran K, Mongrella M, Moskowitz DA, Mustanski B, Macapagal K. It\u2019s Very Inconvenient for Me: A Mixed-Method Study Assessing Barriers and Facilitators of Adolescent Sexual Minority Males Attending PrEP Follow-Up Appointments. AIDS Behav. 2022;26(1):21\u201334.","journal-title":"AIDS Behav"},{"issue":"5","key":"886_CR12","doi-asserted-by":"publisher","first-page":"daac135","DOI":"10.1093\/heapro\/daac135","volume":"37","author":"F Zimbile","year":"2022","unstructured":"Zimbile F, David S, Daemen M, Goossens A, Creemers J, Crutzen R. Introducing video consultations at public sexual health clinics in the Netherlands: a mixed-methods study. Health Promot Int. 2022;37(5):daac135.","journal-title":"Health Promot Int"},{"key":"886_CR13","doi-asserted-by":"crossref","unstructured":"Edwards J. Could the use of digital services improve the provision of HIV PrEP in the UK? BMJ 2022, 377:1562.","DOI":"10.1136\/bmj.o1562"},{"issue":"4","key":"886_CR14","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1007\/s10461-022-03859-3","volume":"27","author":"S Kohler","year":"2023","unstructured":"Kohler S, Dalal S, Hettema A, Matse S, Barnighausen T, Paul N. Out-of-pocket Expenses and Time Spent on Clinic Visits Among HIV Pre-exposure Prophylaxis Users and Other Clinic Attendees in Eswatini. AIDS Behav. 2023;27(4):1222\u201333.","journal-title":"AIDS Behav"},{"issue":"5","key":"886_CR15","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.3390\/ijerph19053002","volume":"19","author":"V Kularadhan","year":"2022","unstructured":"Kularadhan V, Gan J, Chow EPF, Fairley CK, Ong JJ. HIV and STI testing preferences for men who have sex with men in high-income countries: a scoping review. Int J Environ Res Public Health. 2022;19(5):3002.","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"886_CR16","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","volume":"37","author":"KH Mayer","year":"2020","unstructured":"Mayer KH, Agwu A, Malebranche D. Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review. Adv Ther. 2020;37(5):1778\u2013811.","journal-title":"Adv Ther"},{"issue":"11","key":"886_CR17","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1007\/s10461-020-02855-9","volume":"24","author":"A Hillis","year":"2020","unstructured":"Hillis A, Germain J, Hope V, McVeigh J, Van Hout MC. Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex with Men (MSM): A Scoping Review on PrEP Service Delivery and Programming. AIDS Behav. 2020;24(11):3056\u201370.","journal-title":"AIDS Behav"},{"issue":"2","key":"886_CR18","doi-asserted-by":"publisher","first-page":"e25673","DOI":"10.1002\/jia2.25673","volume":"24","author":"JJ Ong","year":"2021","unstructured":"Ong JJ, Fu H, Baggaley RC, Wi TE, Tucker JD, Smith MK, Rafael S, Falconer J, Terris-Prestholt F, Mameletzis I, et al. Missed opportunities for sexually transmitted infections testing for HIV pre-exposure prophylaxis users: a systematic review. J Int AIDS Soc. 2021;24(2):e25673.","journal-title":"J Int AIDS Soc"},{"key":"886_CR19","unstructured":"Not, PrEPared. Barriers to accessing HIV prevention drugs in England. November 2022. Link to report: file:\/\/\/W:\/Downloads\/Barriers-to-PrEP-in-England.pdf."},{"key":"886_CR20","doi-asserted-by":"publisher","first-page":"e51023","DOI":"10.2196\/51023","volume":"12","author":"ML Groot Bruinderink","year":"2023","unstructured":"Groot Bruinderink ML, Boyd A, Coyer L, Boers S, Blitz L, Brand JM, Gotz HM, Stip M, Woudstra J, Yap K, et al. Online-Mediated HIV Pre-exposure Prophylaxis Care and Reduced Monitoring Frequency for Men Who Have Sex With Men: Protocol for a Randomized Controlled Noninferiority Trial (EZI-PrEP Study). JMIR Res Protoc. 2023;12:e51023.","journal-title":"JMIR Res Protoc"},{"issue":"3","key":"886_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/eurpub\/ckr093","volume":"22","author":"J Mindell","year":"2011","unstructured":"Mindell J, Aresu M, B\u00e9cares L, Tolonen H. Representativeness of participants in a cross-sectional health survey by time of day and day of week of data collection. Eur J Pub Health. 2011;22(3):364\u20139.","journal-title":"Eur J Pub Health"},{"issue":"3","key":"886_CR22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s11121-014-0513-z","volume":"16","author":"EA Stuart","year":"2015","unstructured":"Stuart EA, Bradshaw CP, Leaf PJ. Assessing the generalizability of randomized trial results to target populations. Prev Sci. 2015;16(3):475\u201385.","journal-title":"Prev Sci"},{"issue":"9453","key":"886_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0140-6736(04)17670-8","volume":"365","author":"PM Rothwell","year":"2005","unstructured":"Rothwell PM. External validity of randomised controlled trials:to whom do the results of this trial apply? Lancet. 2005;365(9453):82\u201393.","journal-title":"Lancet"},{"key":"886_CR24","unstructured":"Urbanus AT, Blom C. David S: Implementatie PrEP-verstrekking en medische begeleiding in Nederland. In. Rijksinstituut voor Volksgezondheid en Milieu. 2018. https:\/\/zoek.officielebekendmakingen.nl\/blg-872235.pdf."},{"key":"886_CR25","unstructured":"HIV Pre-expositie profylaxe (PrEP.) richtlijn Nederland versie 2\u201315 april 2019. https:\/\/nvhb.nl\/wp-content\/uploads\/2019\/04\/PrEP-richtlijn-Nederland-versie-2-dd-15-april-2019.pdf."},{"issue":"9","key":"886_CR26","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"886_CR27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1207\/s15327752jpa6203_1","volume":"62","author":"SC Kalichman","year":"1994","unstructured":"Kalichman SC, Johnson JR, Adair V, Rompa D, Multhauf K, Kelly JA. Sexual sensation seeking: scale development and predicting AIDS-risk behavior among homosexually active men. J Pers Assess. 1994;62(3):385\u201397.","journal-title":"J Pers Assess"},{"issue":"3","key":"886_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1207\/S15327752JPA7603_02","volume":"76","author":"SC Kalichman","year":"2001","unstructured":"Kalichman SC, Rompa D. The Sexual Compulsivity Scale: further development and use with HIV-positive persons. J Pers Assess. 2001;76(3):379\u201395.","journal-title":"J Pers Assess"},{"issue":"2","key":"886_CR29","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1530-0277.2002.tb02534.x","volume":"26","author":"DF Reinert","year":"2002","unstructured":"Reinert DF, Allen JP. The Alcohol Use Disorders Identification Test (AUDIT): a review of recent research. Alcohol Clin Exp Res. 2002;26(2):272\u20139.","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"886_CR30","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1530-0277.2002.tb02534.x","volume":"26","author":"DF Reinert","year":"2006","unstructured":"Reinert DF, Allen JP. The Alcohol Use Disorders Identification Test (AUDIT): A Review of Recent Research. Alcoholism: Clin Experimental Res. 2006;26(2):272\u20139.","journal-title":"Alcoholism: Clin Experimental Res"},{"key":"886_CR31","volume-title":"The alcohol use disorders identification test: guideline for use in primary care. In","author":"TFH-BJ Babor","year":"2001","unstructured":"Babor TFH-BJ, Saunders JB, Monteiro MG. The alcohol use disorders identification test: guideline for use in primary care. In. Geneva: World Health Organization; 2001."},{"issue":"1","key":"886_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000081413","volume":"11","author":"AH Berman","year":"2005","unstructured":"Berman AH, Bergman H, Palmstierna T, Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res. 2005;11(1):22\u201331.","journal-title":"Eur Addict Res"},{"key":"886_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jsat.2015.01.008","volume":"53","author":"M Hildebrand","year":"2015","unstructured":"Hildebrand M. The psychometric properties of the drug use disorders identification test (DUDIT): a review of recent research. J Subst Abuse Treat. 2015;53:52\u20139.","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"886_CR34","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/sextrans-2015-052052","volume":"91","author":"A Bourne","year":"2015","unstructured":"Bourne A, Reid D, Hickson F, Torres-Rueda S, Weatherburn P. Illicit drug use in sexual settings (\u2018chemsex\u2019) and HIV\/STI transmission risk behaviour among gay men in South London: findings from a qualitative study. Sex Transm Infect. 2015;91(8):564\u20138.","journal-title":"Sex Transm Infect"},{"issue":"2","key":"886_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1530-0277.2006.00295.x","volume":"31","author":"DF Reinert","year":"2007","unstructured":"Reinert DF, Allen JP. The alcohol use disorders identification test: an update of research findings. Alcohol Clin Exp Res. 2007;31(2):185\u201399.","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"886_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","volume":"1","author":"KJ Rothman","year":"1990","unstructured":"Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43\u20136.","journal-title":"Epidemiology"},{"key":"886_CR37","unstructured":"Kayaert L, Sarink D, Visser M, van Wees D, Willemstein I, Op de Coul E, Alexiou Z, de Vries A, Kusters J, van Aar F, et al. Sexually transmitted infections in the Netherlands in 2022. In: Seksueel overdraagbare aandoeningen in Nederland in 2022. Rijksinstituut voor Volksgezondheid en Milieu RIVM: Bilthoven; 2023."},{"issue":"7","key":"886_CR38","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/cid\/ciu450","volume":"59","author":"MM Solomon","year":"2014","unstructured":"Solomon MM, Mayer KH, Glidden DV, Liu AY, McMahan VM, Guanira JV, Chariyalertsak S, Fernandez T, Grant RM. Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trial. Clin Infect Dis. 2014;59(7):1020\u20136.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"886_CR39","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/QAI.0b013e3181c3ef29","volume":"53","author":"KT Bernstein","year":"2010","unstructured":"Bernstein KT, Marcus JL, Nieri G, Philip SS, Klausner JD. Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. JAIDS J Acquir Immune Defic Syndr. 2010;53(4):537\u201343.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"8","key":"886_CR40","doi-asserted-by":"publisher","first-page":"e26317","DOI":"10.1002\/jia2.26317","volume":"27","author":"VW Jongen","year":"2024","unstructured":"Jongen VW, Daans C, van Sighem A, van der Schim M, Hage K, Welling C, von Vaupel-Klein A, den Heijer M, Peters EJ, van der Valk M. Assessing the HIV care continuum among transgender women during 11 years of follow\u2010up: results from the Netherlands\u2019 ATHENA observational cohort. J Int AIDS Soc. 2024;27(8):e26317.","journal-title":"J Int AIDS Soc"},{"issue":"12","key":"886_CR41","doi-asserted-by":"publisher","first-page":"e0260063","DOI":"10.1371\/journal.pone.0260063","volume":"16","author":"SE Stutterheim","year":"2021","unstructured":"Stutterheim SE, van Dijk M, Wang H, Jonas KJ. The worldwide burden of HIV in transgender individuals: an updated systematic review and meta-analysis. PLoS ONE. 2021;16(12):e0260063.","journal-title":"PLoS ONE"},{"key":"886_CR42","doi-asserted-by":"publisher","first-page":"101661","DOI":"10.1016\/j.eclinm.2022.101661","volume":"53","author":"D Santoso","year":"2022","unstructured":"Santoso D, Asfia SK, Mello MB, Baggaley RC, Johnson CC, Chow EP, Fairley CK, Ong JJ. HIV prevalence ratio of international migrants compared to their native-born counterparts: a systematic review and meta-analysis. EClinicalMedicine. 2022;53:101661.","journal-title":"EClinicalMedicine"},{"issue":"8","key":"886_CR43","doi-asserted-by":"publisher","first-page":"e651","DOI":"10.1016\/S2468-2667(23)00105-6","volume":"8","author":"W Tieosapjaroen","year":"2023","unstructured":"Tieosapjaroen W, Zhang Y, Fairley CK, Zhang L, Chow EP, Phillips TR, Schmidt H-M, Bavinton BR, O\u2019Donnell D, Mao L. Improving access to oral pre-exposure prophylaxis for HIV among international migrant populations. Lancet Public Health. 2023;8(8):e651\u20138.","journal-title":"Lancet Public Health"},{"issue":"5","key":"886_CR44","doi-asserted-by":"publisher","first-page":"e308","DOI":"10.1016\/S2352-3018(23)00008-5","volume":"10","author":"AL Wirtz","year":"2023","unstructured":"Wirtz AL, Humes E, Althoff KN, Poteat TC, Radix A, Mayer KH, Schneider JS, Haw JS, Wawrzyniak AJ, Cannon CM. HIV incidence and mortality in transgender women in the eastern and southern USA: a multisite cohort study. Lancet HIV. 2023;10(5):e308\u201319.","journal-title":"Lancet HIV"},{"key":"886_CR45","doi-asserted-by":"publisher","first-page":"105124","DOI":"10.1016\/j.ijmedinf.2023.105124","volume":"177","author":"M Estrela","year":"2023","unstructured":"Estrela M, Semedo G, Roque F, Ferreira PL, Herdeiro MT. Sociodemographic determinants of digital health literacy: a systematic review and meta-analysis. Int J Med Informatics. 2023;177:105124.","journal-title":"Int J Med Informatics"},{"issue":"12","key":"886_CR46","first-page":"e34754","volume":"6","author":"S Plantinga","year":"2018","unstructured":"Plantinga S, Kaal M. Hoe mediawijs is Nederland? Mediawijzer Kantar Public. 2018;6(12):e34754.","journal-title":"Mediawijzer Kantar Public"},{"issue":"4","key":"886_CR47","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/ijerph16040645","volume":"16","author":"F Reiners","year":"2019","unstructured":"Reiners F, Sturm J, Bouw LJ, Wouters EJ. Sociodemographic factors influencing the use of eHealth in people with chronic diseases. Int J Environ Res Public Health. 2019;16(4):645.","journal-title":"Int J Environ Res Public Health"},{"key":"886_CR48","doi-asserted-by":"publisher","first-page":"e44181","DOI":"10.2196\/44181","volume":"25","author":"KE Woolley","year":"2023","unstructured":"Woolley KE, Bright D, Ayres T, Morgan F, Little K, Davies AR. Mapping inequities in digital health technology within the World Health Organization\u2019s European Region using PROGRESS PLUS: scoping review. J Med Internet Res. 2023;25:e44181.","journal-title":"J Med Internet Res"},{"issue":"1S","key":"886_CR49","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1097\/QAI.0000000000003340","volume":"95","author":"EL Korenromp","year":"2024","unstructured":"Korenromp EL, Sabin K, Stover J, Brown T, Johnson LF, Martin-Hughes R, Ten Brink D, Teng Y, Stevens O, Silhol R. New HIV infections among key populations and their partners in 2010 and 2022, by world region: a multisources estimation. JAIDS J Acquir Immune Defic Syndr. 2024;95(1S):e34\u201345.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"10434","key":"886_CR50","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/S0140-6736(24)00302-7","volume":"403","author":"C Beyrer","year":"2024","unstructured":"Beyrer C, Kamarulzaman A, Isbell M, Amon J, Baral S, Bassett MT, Cepeda J, Deacon H, Dean L, Fan L. Under threat: the International AIDS Society\u2013Lancet Commission on health and human rights. Lancet. 2024;403(10434):1374\u2013418.","journal-title":"Lancet"},{"issue":"10148","key":"886_CR51","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S0140-6736(18)31439-9","volume":"392","author":"K Shannon","year":"2018","unstructured":"Shannon K, Crago A-L, Baral SD, Bekker L-G, Kerrigan D, Decker MR, Poteat T, Wirtz AL, Weir B, Boily M-C. The global response and unmet actions for HIV and sex workers. Lancet. 2018;392(10148):698\u2013710.","journal-title":"Lancet"},{"issue":"4","key":"886_CR52","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1136\/sextrans-2023-056061","volume":"100","author":"H Van Mieghem","year":"2024","unstructured":"Van Mieghem H, N\u00f6stlinger C, Smekens T, De Canni\u00e8re A-S, Keersmaekers K, Scheerder G, De Baetselier I, Vuylsteke B. Identifying priority groups for pre-exposure prophylaxis among sex workers in Flanders, Belgium: insights into routine HIV and sexually transmitted infection data in community-based clinics. Sex Transm Infect. 2024;100(4):236\u201341.","journal-title":"Sex Transm Infect"},{"issue":"4","key":"886_CR53","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/jrh.12645","volume":"38","author":"JD Sharpe","year":"2022","unstructured":"Sharpe JD, Sanchez TH, Siegler AJ, Guest JL, Sullivan PS. Association between the geographic accessibility of PrEP and PrEP use among MSM in nonurban areas. J Rural Health. 2022;38(4):948\u201359.","journal-title":"J Rural Health"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-026-00886-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00886-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00886-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:43:29Z","timestamp":1783914209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12981-026-00886-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["886"],"URL":"https:\/\/doi.org\/10.1186\/s12981-026-00886-1","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The EZI-PrEP Trial was approved by the medical ethics committee of the Amsterdam University Medical Centre, file number 2020_154-NL74494.018.20. The trial has been registered with ClinicalTrials.gov, trial number NCT05093036 and the European general data privacy regulation following data and privacy impact assessments to protect participants\u2019 privacy and confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"UD received unrestricted research grants and speaker fees from Gilead Sciences, and participated in Advisory boards of ViiV, all fees and grants paid to his institute. MFSvdL participated in Advisory Boards of Merck Sharp & Dohme, for which fees were paid to his institute. MFSvdL received a research grant from GlaxoSmithKline, paid to his institute. AB received speaker\u2019s fees from Gilead Sciences. EH received unrestricted research grants from Gilead Sciences, paid to her institute. MP received unrestricted research grants and speaker\/advisory fees from Gilead Sciences and Merck Sharp & Dohme, all paid to her institute. All other authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}